Current approaches to monitoring and management of heart failure

Reviews in Cardiovascular Medicine

Volumn 7, Issue SUPPL. 1, 2006, Pages

  Yancy, Clyde W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

B type natriuretic peptide; Congestive heart failure; Decompensation; Heart failure monitoring

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; ISOSORBIDE DINITRATE;

ALGORITHM; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; HEART FAILURE; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE WALL; HEART STRESS; HEART VENTRICLE PRESSURE; HEMODYNAMIC MONITORING; HOSPITALIZATION; HUMAN; IMPEDANCE CARDIOGRAPHY; MONITOR; PATIENT CARE; PATIENT MONITORING; PRACTICE GUIDELINE; PREDICTION; PROTEIN SYNTHESIS; SYMPTOMATOLOGY;

BIOLOGICAL MARKERS; CARDIOGRAPHY, IMPEDANCE; EARLY DIAGNOSIS; EDEMA; EDEMA, CARDIAC; HEART CATHETERIZATION; HEART FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PULMONARY WEDGE PRESSURE; VENTRICULAR FUNCTION, LEFT;

EID: 33749071020     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:1116-1143.
2. American Heart Association. Heart Disease and Stroke Statistics - 2006 Update. Dallas, TX: American Heart Association; 2006.
3. Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV. Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med. 2002;162:1689-1694.
4. The VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287:1531.
5. Fonarow GC for the ADHERE Scientific Advisory Committee. The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med. 2003;4(suppl 7):S21-S30.
6. The Adhere Scientific Advisory Committee. Insights from the ADHERE® registry: Data from over 100,000 patient cases. Available at: http://www.adhereregistry.com/ADHERE_100k.pdf. Accessed August 20, 2006.
7. Gheorghiade M, Gattis WA, O'Connor CM, et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA. 2004;291:1963-1971.
8. Lucas C, Johnson W, Hamilton MA, et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J. 2000;140:840.
9. Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 2001; 345:574-581.
10. Goldberg LR, Piette JD, Walsh MN, et al. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J. 2003;146:705-712.
11. Silver MA Maisel A, Yancy CW, et al. BNP consensus panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail. 2004;10:1-30.
12. Maisel AS, Krishnaswamy P, Novak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.
13. Dao Q, Krishnaswamy P, Kazenegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol. 2001;37:379-385.
14. Januzzi JL, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005;95:948-954.
15. Maisel A. B-Type Natriuretic Peptide Measurements in Diagnosing Congestive Heart Failure in the Dyspneic Emergency Department Patient. Rev Cardiovasc Med. 2002;3(suppl 4): S10-S17.
16. Fonarow GC, Horwich TB. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure. Rev Cardiovasc Med. 2003;4(suppl 4):S20-S28.
17. Logeart D, Thabut G, Jourdain P, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol. 2004;43:635-641.
18. Yancy C, Abraham W. Noninvasive hemodynamic monitoring in heart failure: utilization of impedance cardiography. Congest Heart Fail. 2003;9:241-250.
19. Packer M, Abraham WT, Mehra M, et al. Utility of impendance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure [PREDICT]. J Am Coll Cardiol. 2006; 47:2245-2252.
20. The ESCAPE Investigators and ESCAPE Study Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005;294:1625-1633.
21. Fonarow GC, Adams KF Jr, Abraham WT, et al., for the ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572-580.
22. Adamson PB, Kjellstrom B, Braunschweig F, et al. Ambulatory hemodynamic monitoring from an implanted device: components of continuous 24-hour pressures that correlate to supine resting conditions and acute right heart catheterization. Congest Heart Fail. 2006;12: 14-19.
23. Yu CM, Wang L, Chan E, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. 2005;112:841-848.